[1]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1437353,2004,A1Locationinpatent:Page62;63
[2]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1437353,2004,A1Locationinpatent:Page63
[3]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1437353,2004,A1Locationinpatent:Page63
[4]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn39
[5]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn39-40
[6]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn40
[7]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn40-41
[8]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn40
[9]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn41
[10]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn40
[11]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn41
[12]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn42
[13]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1864978,2007,A1Locationinpatent:Page/Pagecolumn41
[1]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1437353,2004,A1Locationinpatent:Page50
[2]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP1614419,2006,A1Locationinpatent:Page/Pagecolumn22-23
[1]CurrentPatentAssignee:FUJIFILMHOLDINGSCORP.-EP2287160,2011,A1Locationinpatent:Page/Pagecolumn6-7
Title: T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period.
Journal: Journal of psychiatric research 20120501
Title: T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.
Journal: Biochemical and biophysical research communications 20110422
Title: [Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100701
Title: T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide.
Journal: British journal of pharmacology 20090601
Title: A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Journal: Neuropharmacology 20081001
Title: Neuroprotective effects of T-817MA against noise-induced hearing loss.
Journal: Neuroscience research 20080501
Title: T-817MA, a novel neurotrophic compound, ameliorates phencyclidine-induced disruption of sensorimotor gating.
Journal: Psychopharmacology 20080401
Title: Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats.
Journal: Hippocampus 20070101
Title: T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons.
Journal: Neurochemistry international 20060101
Title: A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
Journal: The Journal of pharmacology and experimental therapeutics 20050701
Title: Hirata K, et al. A novel neurotrophic agent, T-817MA -{3--(1-benzothiophen-5-yl) ethoxy propyl}-3-azetidinol maleate, attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons. J Pharmacol Exp Ther. 2005 Jul;314(1):252-9.
Title: Kimura T, et al. T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide. Br J Pharmacol. 2009 Jun;157(3):451-63.
